Compounds > telmisartan
Page last updated: 2024-08-24

telmisartan and No-Reflow Phenomenon

telmisartan has been researched along with No-Reflow Phenomenon in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, Z; Sun, B; Tan, Q1

Other Studies

1 other study(ies) available for telmisartan and No-Reflow Phenomenon

ArticleYear
Telmisartan ameliorates vascular endothelial dysfunction in coronary slow flow phenomenon (CSFP).
    Cell biochemistry and function, 2018, Volume: 36, Issue:1

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Male; Middle Aged; No-Reflow Phenomenon; Rabbits; Structure-Activity Relationship; Telmisartan

2018